Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Singular Genomics Systems, Inc. (OMIC)
since 2021 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Singular Genomics Systems, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1850906.
Total stock buying since 2021: $35,268,851.
Total stock sales since 2021: $399,608.
Total stock option exercises since 2021: $93,423.
Table 3. Detailed insider trading at Singular Genomics Systems, Inc. (OMIC)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-02-14 | Spaventa Andrew (Chief Executive Officer) | Sale | 800 | 19.89 | 15,912 |
| 2025-02-12 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 1,907 | .00 | 0 |
| 2025-02-09 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 250 | .00 | 0 |
| 2025-02-09 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 500 | .00 | 0 |
| 2025-02-09 | Meeter Dalen (Chief Financial Officer) | Option Ex | 500 | .00 | 0 |
| 2025-01-02 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 417 | .00 | 0 |
| 2024-12-16 | Spaventa Andrew (Chief Executive Officer) | Sale | 180 | 20.16 | 3,629 |
| 2024-12-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 486 | .00 | 0 |
| 2024-12-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 250 | .00 | 0 |
| 2024-12-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 209 | .00 | 0 |
| 2024-11-12 | Spaventa Andrew (Chief Executive Officer) | Sale | 695 | 22.55 | 15,668 |
| 2024-11-12 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 1,907 | .00 | 0 |
| 2024-11-09 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 250 | .00 | 0 |
| 2024-11-09 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 500 | .00 | 0 |
| 2024-11-09 | Meeter Dalen (Chief Financial Officer) | Option Ex | 500 | .00 | 0 |
| 2024-10-02 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 1,666 | .00 | 0 |
| 2024-09-18 | Tang Capital Partners Lp | Buy | 32,000 | 17.21 | 550,720 |
| 2024-09-17 | Tang Capital Partners Lp | Buy | 40,000 | 15.33 | 613,200 |
| 2024-09-16 | Tang Capital Partners Lp | Buy | 50,416 | 12.74 | 642,299 |
| 2024-09-15 | Spaventa Andrew (Chief Executive Officer) | Sale | 175 | 12.38 | 2,166 |
| 2024-09-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 487 | .00 | 0 |
| 2024-09-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 250 | .00 | 0 |
| 2024-09-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 209 | .00 | 0 |
| 2024-08-12 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 1,906 | .00 | 0 |
| 2024-08-09 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 250 | .00 | 0 |
| 2024-08-09 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 500 | .00 | 0 |
| 2024-08-09 | Meeter Dalen (Chief Financial Officer) | Option Ex | 500 | .00 | 0 |
| 2024-06-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 14,584 | .00 | 0 |
| 2024-06-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2024-06-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2024-05-12 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 57,188 | .00 | 0 |
| 2024-05-09 | Ghai Jyotsna (Chief Operating Officer) | Option Ex | 7,500 | .00 | 0 |
| 2024-05-09 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 15,000 | .00 | 0 |
| 2024-05-09 | Meeter Dalen (Chief Financial Officer) | Option Ex | 15,000 | .00 | 0 |
| 2024-03-15 | Ropp Sam (Chief Commercial Officer) | Option Ex | 4,187 | .00 | 0 |
| 2024-03-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 14,583 | .00 | 0 |
| 2024-03-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2024-03-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2023-12-15 | Ropp Sam (Chief Commercial Officer) | Option Ex | 4,188 | .00 | 0 |
| 2023-12-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 14,583 | .00 | 0 |
| 2023-12-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2023-12-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2023-11-17 | Spaventa Andrew (Chief Executive Officer) | Buy | 75,000 | .42 | 31,725 |
| 2023-11-16 | Spaventa Andrew (Chief Executive Officer) | Buy | 43,468 | .41 | 17,865 |
| 2023-11-16 | Glezer Eli N. (Chief Scientific Officer) | Buy | 200,000 | .43 | 85,600 |
| 2023-09-15 | Ropp Sam (Chief Commercial Officer) | Option Ex | 4,187 | .00 | 0 |
| 2023-09-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 14,584 | .00 | 0 |
| 2023-09-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2023-09-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2023-08-15 | Kamdar Kim P. (Director) | Sale | 200,000 | .54 | 107,000 |
| 2023-08-14 | Kamdar Kim P. (Director) | Sale | 77,991 | .57 | 44,454 |
| 2023-08-11 | Kamdar Kim P. (Director) | Sale | 353,657 | .60 | 210,779 |
| 2023-06-15 | Ropp Sam (Chief Commercial Officer) | Option Ex | 4,188 | .00 | 0 |
| 2023-06-15 | Spaventa Andrew (Chief Executive Officer) | Option Ex | 14,583 | .00 | 0 |
| 2023-06-15 | Glezer Eli N. (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2023-06-15 | Meeter Dalen (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
| 2023-05-17 | Glezer Eli N. (Chief Scientific Officer) | Buy | 170,000 | .82 | 138,890 |
| 2022-12-12 | Glezer Eli N. (Chief Scientific Officer) | Buy | 50,000 | 2.00 | 100,000 |
| 2022-07-07 | Barker David L (Director) | Option Ex | 60,000 | .63 | 37,800 |
| 2022-05-31 | Pellini Michael J (Director) | Option Ex | 154,939 | .36 | 55,623 |
| 2022-05-18 | Pellini Michael J (Director) | Buy | 26,834 | 3.30 | 88,552 |
| 2021-06-01 | Deerfield Private Design Fund Iv, L.p. | Buy | 1,500,000 | 22.00 | 33,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of OMIC listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Singular Genomics Systems, Inc. (symbol OMIC,
CIK number 1850906) see
the Securities and Exchange Commission (SEC) website.